Evaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular Edema

BACKGROUND/AIMS: Bevacizumab and ranibizumab are routinely used to treat diabetic macular edema (DME). We aim to evaluate the usefulness of switching to ranibizumab therapy following bevacizumab treatment failure in eyes with DME. METHODS: We performed a retrospective analysis of a consecutive group...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanhart, Joel, Chowers, Itay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: February, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357677/
https://www.ncbi.nlm.nih.gov/pubmed/25802504
http://dx.doi.org/10.1159/000375230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357677/
https://www.ncbi.nlm.nih.gov/pubmed/25802504
http://dx.doi.org/10.1159/000375230

Ejemplares similares